StocksMedium•9 November 2026•
1 min read
KALA BIO Narrows Preliminary Q3 Net Loss to $0.8 Million
Key Facts
1KALA BIO reported a preliminary net loss of approximately $0.8 million for Q3 2026, compared to $7.6 million in Q3 2025.
KALA BIO reported a preliminary net loss of approximately $0.8 million for the third quarter of 2026. Newsfile Corp reported that this figure represents a significant reduction from the $7.6 million net loss recorded in the third quarter of 2025. The preliminary unaudited announcement also included an update regarding the company's executive leadership.
KALA closed at $0.1559 on November 6, 2026, with the stock trading between a day low of $0.15118 and a high of $0.17 during that session. The company is providing these financial results as part of its quarterly reporting cycle to maintain transparency regarding its performance and management structure.